Sign in
WithdrawnNo phase

Suboxone Dispenser for OUD

Key facts

Who runs it
Addinex Technologies, Inc.
Where
Greenwich, United StatesSee the site
Trial code
Status
Withdrawn
Started
15 Jan 2024
Ended
31 Aug 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Addinex
Record updated
28 May 2025
Why it stopped
Study was discontinued at the primary site due to change in site management.

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • A minimum of 18 years old at admission of study
  • Primary or secondary diagnosis of opioid use disorder (DSM-5; APA, 2013) diagnosis by clinician
  • Prospective patients have to select 'Yes' they are interested in Yale-approved research studies while enrolled at Aware Recovery Care and that researchers can contact them about research projects

Who cannot take part

  • Meets criterion of DSM-V (APA, 2013) for bi-polar, schizophrenia, or psychiatric disorders
  • Unable to read and understand English at 5th grade level
  • Unable to complete the study because of anticipated incarceration or move
  • Life threatening or unstable medical problems
  • Current suicide or homicide risk
  • Anticipated/current pregnancy, or breastfeeding

Where in United States

  • Greenwich HospitalGreenwich, United States

About the trial

What the trial wants to find out

The goal of this study is to evaluate the usability and acceptability of the Addinex system with patients receiving Suboxone in OUD treatment. The main questions it aims to answer are:

Read full original descriptionShow less

* Are patients more likely to stay on their medication? * Is the risk of diversion being reduced? * How is the usability of the Addinex system for doctors and patients?

The 2 groups in the trial

  • ControlExisting treatment, for comparison

    Patients in this arm will undergo standard at-home OUD treatment (n = 5/group) over 14-days.

    Treatment: Addinex

  • Active - AppTreatment being tested

    Patients in this arm will undergo standard at-home OUD treatment in combination with the Addinex dispenser and app (n = 5/group) over 14-days.

    Treatment: Addinex

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Development of a Telehealth Medication-assisted Treatment (MAT) System for Patients With Opioid Use Disorder (OUD)
Record updated
28 May 2025